Tezspire 210 mg/1.91 mL (110 mg/mL) injection Images
Generic Name: tezepelumab
This medication has been identified as Tezspire 210 mg/1.91 mL (110 mg/mL) injection. It is supplied by Amgen Inc.
Tezspire is used in the treatment of Asthma and belongs to the drug class selective immunosuppressants. Tezspire 210 mg/1.91 mL (110 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Tezspire
- Generic Name
- tezepelumab
- Strength
- 210 mg/1.91 mL (110 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0100
More about Tezspire (tezepelumab)
- Check interactions
- Compare alternatives
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
